Leukemia, Lymphocytic, Chronic Clinical Trial
Official title:
Autologous and Allogeneic Peripheral Blood Progenitor (PBPC) Transplantation for Patients With Chronic Lymphocytic Leukemia
To evaluate the role of high dose therapy and autologous or allogeneic hematopoietic cell transplantation for the treatment of chronic lymphocytic leukemia.
To determine effectiveness of allogeneic transplantation in eradicating chronic lymphocytic leukemia. ;
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03204188 -
Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
|
Phase 2 | |
| Completed |
NCT02758665 -
Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL
|
Phase 2 | |
| Terminated |
NCT00393380 -
Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor
|
Phase 2 | |
| Terminated |
NCT00176930 -
Stem Cell Transplant for Hematological Malignancy
|
N/A | |
| Completed |
NCT00562224 -
Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients
|
Phase 1 | |
| Completed |
NCT00270049 -
Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia
|
Phase 2 | |
| Terminated |
NCT02440685 -
A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Terminated |
NCT00083473 -
A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia
|
Phase 2 | |
| Completed |
NCT04030195 -
Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL
|
Phase 1/Phase 2 | |
| Completed |
NCT00464633 -
Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)
|
Phase 2 | |
| Terminated |
NCT00290407 -
Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)
|
Phase 2 | |
| Completed |
NCT00055146 -
Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)
|
Phase 2 | |
| Not yet recruiting |
NCT05154474 -
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
|
||
| Completed |
NCT00289549 -
Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)
|
Phase 2 | |
| Terminated |
NCT01045382 -
MSC and HSC Coinfusion in Mismatched Minitransplants
|
Phase 2 | |
| Terminated |
NCT01050946 -
Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit
|
Phase 2 | |
| Completed |
NCT00283101 -
A Safety Study in Patients With Chronic Lymphocytic Leukemia
|
Phase 1/Phase 2 | |
| Completed |
NCT00546793 -
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
|
Phase 1/Phase 2 | |
| Terminated |
NCT00167180 -
Post Transplant Donor Lymphocyte Infusion
|
Phase 2 | |
| Completed |
NCT00535912 -
Phase III Study Treatment of CLL B and C
|
Phase 3 |